Clinical Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pandya, A. Y.
Right arrow Articles by Ruppert, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pandya, A. Y.
Right arrow Articles by Ruppert, J. M.
Clinical Cancer Research Vol. 10, 2709-2719, April 15, 2004
© 2004 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Nuclear Localization of KLF4 Is Associated with an Aggressive Phenotype in Early-Stage Breast Cancer

Ashka Y. Pandya1, Lynya I. Talley2, Andra R. Frost3, Thomas J. Fitzgerald2, Vivek Trivedi2, Mithun Chakravarthy3, David C. Chhieng3, William E. Grizzle3, Jeffrey A. Engler5, Helen Krontiras4, Kirby I. Bland4, Albert F. LoBuglio2, Susan M. Lobo-Ruppert2 and J. Michael Ruppert2

1 Department of Cell Biology, 2 Department of Medicine, Division of Hematology/Oncology, 3 Department of Pathology, 4 Department of Surgery, and 5 Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, Alabama

Purpose: The Krüppel-like transcription factor KLF4/GKLF induces both malignant transformation and a slow-growth phenotype in vitro. Although KLF4 expression is increased in most cases of breast cancer, it was unknown whether these cases represent a distinct subtype with a different clinical outcome.

Experimental Design: We examined expression of KLF4 by immunostaining 146 cases of human primary infiltrating ductal carcinoma of the breast. Staining patterns were correlated with clinical outcome and with established prognostic factors.

Results: Subcellular localization exhibited case-to-case variation. Tumors with high nuclear staining and low cytoplasmic staining were termed type 1. For patients with early-stage disease (i.e., stage I or IIA), type 1 staining was associated with eventual death because of breast cancer (hazard ratio, 2.8; 95% confidence interval, 1.23–6.58; P = 0.011). The association was stronger in patients with early-stage cancer and small primary tumors (i.e., <=2.0 cm in diameter; hazard ratio, 4.3; 95% confidence interval, 1.75–10.62; P < 0.001). For patients with early-stage disease, multivariate analysis indicated that type 1 staining was independently associated with outcome (adjusted hazard ratio 2.6; 95% confidence interval, 1.10–6.05; P = 0.029). Type 1 staining was also associated with high histological grade (P = 0.032), increased expression of Ki67 (P = 0.016), and reduced expression of BCL2 (P = 0.032). In vitro, KLF4 was localized within the nucleus of transformed RK3E epithelial cells, consistent with a nuclear function of this transcription factor during induction of malignant transformation.

Conclusions: The results suggest that localization of KLF4 in the nucleus of breast cancer cells is a prognostic factor and identify KLF4 as a marker of an aggressive phenotype in early-stage infiltrating ductal carcinoma.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. M. Evans, W. Zhang, X. Chen, J. Yang, K. K. Bhakat, and C. Liu
Kruppel-like Factor 4 Is Acetylated by p300 and Regulates Gene Transcription via Modulation of Histone Acetylation
J. Biol. Chem., November 23, 2007; 282(47): 33994 - 34002.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
R. Behr, C. Deller, M. Godmann, T. Muller, M. Bergmann, R. Ivell, and K. Steger
Kruppel-like factor 4 expression in normal and pathological human testes
Mol. Hum. Reprod., November 1, 2007; 13(11): 815 - 820.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Wei, H. Xu, and D. Kufe
Human Mucin 1 Oncoprotein Represses Transcription of the p53 Tumor Suppressor Gene
Cancer Res., February 15, 2007; 67(4): 1853 - 1858.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. S. Suh, J. M. Crutchley, A. Koochek, A. Ryscavage, K. Bhat, T. Tanaka, A. Oshima, P. Fitzgerald, and S. H. Yuspa
Reciprocal Modifications of CLIC4 in Tumor Epithelium and Stroma Mark Malignant Progression of Multiple Human Cancers
Clin. Cancer Res., January 1, 2007; 13(1): 121 - 131.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. Wei, M. Kanai, S. Huang, and K. Xie
Emerging role of KLF4 in human gastrointestinal cancer
Carcinogenesis, January 1, 2006; 27(1): 23 - 31.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. D. Graham, M. L. Yager, H. D. Hill, K. Byth, G. M. O'Neill, and C. L. Clarke
Altered Progesterone Receptor Isoform Expression Remodels Progestin Responsiveness of Breast Cancer Cells
Mol. Endocrinol., November 1, 2005; 19(11): 2713 - 2735.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Li, J. McClintick, L. Zhong, H. J. Edenberg, M. C. Yoder, and R. J. Chan
Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4
Blood, January 15, 2005; 105(2): 635 - 637.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.